Literature DB >> 17280911

Nonurothelial cancer of the bladder.

Hassan Abol-Enein1, Bruce R Kava, Adrienne J K Carmack.   

Abstract

In this article, we review available evidence on the treatment of patients with nonurothelial cancer of the bladder. More than 150 published works were reviewed in preparation for this summary. Squamous cell carcinoma and adenocarcinoma are ideally treated with radical cystectomy. High-risk groups for these diseases are defined. Small cell carcinoma should be treated with multimodality therapy, including chemotherapy. Other rarer tumors of the bladder are also discussed.

Entities:  

Mesh：

Year:  2007        PMID： 17280911     DOI： 10.1016/j.urology.2006.08.1107

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  23 in total

1.  Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Authors:  Reema Railkar; L Spencer Krane; Q Quentin Li; Thomas Sanford; Mohammad Rashid Siddiqui; Diana Haines; Srinivas Vourganti; Sam J Brancato; Peter L Choyke; Hisataka Kobayashi; Piyush K Agarwal
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

2.  Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients.

Authors:  Rania Bakry; Mohamed I El-Sayed; Hesham M Hamza; Khaled H Hassan
Journal:  Oncol Lett       Date:  2015-11-17       Impact factor: 2.967

3.  Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.

Authors:  Behfar Ehdaie; Alexandra Maschino; Shahrokh F Shariat; Jorge Rioja; Robert J Hamilton; William T Lowrance; Stephen A Poon; Hikmat A Al-Ahmadie; Harry W Herr
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

4.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 5.  [Squamous cell lesions of the urinary bladder].

Authors:  S Rausch; N Gaisa; R F Youssef; Y Lotan; A Stenzl; T Kälble
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

Review 6.  Characteristics and clinical significance of histological variants of bladder cancer.

Authors:  Marco Moschini; David D'Andrea; Stephan Korn; Yasin Irmak; Francesco Soria; Eva Compérat; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

7.  The changing patterns of bladder cancer in Egypt over the past 26 years.

Authors:  Ashley S Felix; Amr S Soliman; Hussein Khaled; Mohamed S Zaghloul; Mousumi Banerjee; Manal El-Baradie; Mohamed El-Kalawy; Alaa A Abd-Elsayed; Kadry Ismail; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Mark L Wilson
Journal:  Cancer Causes Control       Date:  2008-01-10       Impact factor: 2.506

8.  Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience.

Authors:  Bin Yu; Jin Zhou; Hongzhou Cai; Ting Xu; Zicheng Xu; Qing Zou; Min Gu
Journal:  BMC Urol       Date:  2015-01-28       Impact factor: 2.264

9.  Orthotopic genital sparing radical cystectomy in pre-menopausal women with muscle-invasive bladder carcinoma: A prospective study.

Authors:  Essam ElDin S Moursy; Mohammed Z Eldahshoursy; Wael M Gamal; Abdelbasset A Badawy
Journal:  Indian J Urol       Date:  2016 Jan-Mar

10.  Urinary Bladder Adenocarcinoma Metastatic to the Abdominal Wall: Report of a Case with Cytohistologic Correlation.

Authors:  Vikas Nath; Mithra Baliga
Journal:  Case Rep Pathol       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.